Cells growing in culture with previously described properties of rat uterine smooth muscle accumulated Ca2+ from the medium. Ca2+ uptake by these cells was stimulated b the addition to the medium of 8-bromo-cCMP but not by 8-bromo-CAMP. Cay+ uptake was also stimulated by carbachol and by the nitro-v
INHIBITION OF PROLIFERATION OF CONTAMINATING FIBROBLASTS BY D-VALINE IN CULTURES OF SMOOTH MUSCLE CELLS FROM HUMAN MYOMETRIUM
✍ Scribed by Jarin Hongpaisan
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 588 KB
- Volume
- 24
- Category
- Article
- ISSN
- 1065-6995
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Replacement of L‐valine with D‐valine in a standard culture medium can selectively inhibit fibroblast proliferation. The aim of the present study was to investigate whether human myometrial cells cultured with D‐valine instead of L‐valine can survive and express their characteristics. Cultured cells (95–98%) maintain expression of the intermediate filament desmin, which is the specific marker for mature muscle cells. By transmission electron microscopy, the cells showed the general morphology of smooth muscle cells in culture. Oxytocin in serum‐free culture medium at 37°C (5min) caused a concentration‐dependent increase in cellular Na and total Ca, and a decrease in K content as determined by X‐ray microanalysis. The percentage of cells cultured with D‐valine responding to oxytocin stimulation was larger than that of cells cultured with L‐valine, suggesting less contamination of smooth muscle cells by fibroblasts in the presence of D‐valine. As shown by measurements with fura‐2, D‐valine‐cultured cells retained the characteristic increase in intracellular free Ca^2+^ions after oxytocin stimulation.
📜 SIMILAR VOLUMES
Smooth muscle cell proliferation is regulated through the coordinated action of growth inhibitors and growth factorslmitogens; a specific heparin-epidermal growth factor (ECF) complementation has been proposed (Reilly et al., 1987, J. Cell. Physiol., 13 1:149-157). In culture, vascular smooth muscle
## Abstract Although lipid‐lowering therapy with 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitors (statins) decreases the progression of coronary artery and aortic valve calcification, the mechanism of action of these drugs to inhibit the calcification process remains unclear. In this stu